Published in J Natl Cancer Inst on April 02, 1997
Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg (2013) 2.12
Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study. Gynecol Oncol (2013) 1.92
Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc (2012) 1.23
Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol (2013) 1.13
Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator. Surg Endosc (2000) 1.06
Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC). J Transl Med (2004) 1.02
Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC). Ann Surg Oncol (2013) 1.02
A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers. Ann Surg Oncol (2008) 1.00
A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance. Neoplasia (2004) 0.97
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis. J Gastrointest Surg (2015) 0.96
Hyperthermic intraoperative thoracoabdominal chemotherapy. Gastroenterol Res Pract (2012) 0.92
Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model. Nat Commun (2014) 0.91
Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease. J Transl Med (2006) 0.91
Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer. Surg Today (2013) 0.90
Peritoneal carcinosis of ovarian origin. World J Gastrointest Oncol (2010) 0.89
Use of an anti-vascular endothelial growth factor antibody in a pharmacokinetic strategy to increase the efficacy of intraperitoneal chemotherapy. J Pharmacol Exp Ther (2009) 0.88
Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy. Curr Drug Discov Technol (2009) 0.88
Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers. Nanomedicine (Lond) (2012) 0.87
Management of peritoneal carcinomatosis from colorectal cancer. Semin Oncol (2011) 0.87
Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface dissemination from ovarian neoplasms. Am J Surg (2011) 0.86
Office-based intraperitoneal chemotherapy for ovarian cancer. J Oncol Pract (2008) 0.86
Feasibility of hyperthermic pressurized intraperitoneal aerosol chemotherapy in a porcine model. Surg Endosc (2015) 0.84
In Vivo Feasibility of Electrostatic Precipitation as an Adjunct to Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC). Ann Surg Oncol (2016) 0.83
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in a woman with pseudomyxoma peritonei: A case report. Gynecol Oncol Rep (2014) 0.83
Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer. World J Gastrointest Oncol (2010) 0.83
Hyperthermic intraperitoneal chemotherapy with melphalan: a summary of clinical and pharmacological data in 34 patients. Gastroenterol Res Pract (2012) 0.81
Pharmacokinetics of Hyperthermic Intrathoracic Chemotherapy following Pleurectomy and Decortication. Gastroenterol Res Pract (2012) 0.80
Pressurized intraperitoneal chemotherapy (PIPAC) in women with gynecologic malignancies: a review. Wien Med Wochenschr (2014) 0.80
Intraperitoneal hyperthermic chemotherapy: experience at Baylor University Medical Center. Proc (Bayl Univ Med Cent) (2002) 0.80
Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study. BMC Cancer (2011) 0.80
Drug development for intraperitoneal chemotherapy against peritoneal carcinomatosis from gastrointestinal cancer. Surg Today (2014) 0.79
A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C. J Surg Res (2012) 0.79
Pharmacokinetics of the perioperative use of cancer chemotherapy in peritoneal surface malignancy patients. Gastroenterol Res Pract (2012) 0.77
Site-Specific In Vivo Bioorthogonal Ligation via Chemical Modulation. Adv Healthc Mater (2016) 0.76
Pharmacokinetic and pharmacodynamic analysis of hyperthermic intraperitoneal oxaliplatin-induced neutropenia in subjects with peritoneal carcinomatosis. AAPS J (2011) 0.76
Does hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patients. Patient Saf Surg (2012) 0.75
Design of optimized hypoxia-activated prodrugs using pharmacokinetic/pharmacodynamic modeling. Front Oncol (2013) 0.75
Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals. J Control Release (2016) 0.75
Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study. Gastroenterol Res Pract (2017) 0.75
Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study. Br J Cancer (2011) 0.75
Preclinical activity of melflufen (J1) in ovarian cancer. Oncotarget (2016) 0.75
Solid-organ transplantation in older adults: current status and future research. Am J Transplant (2012) 1.33
A distributed model of peritoneal-plasma transport: theoretical considerations. Am J Physiol (1984) 1.10
Net acid transport by isolated perfused inner medullary collecting ducts. Am J Physiol (1990) 0.94
Peritoneal lymphatic uptake of fibrinogen and erythrocytes in the rat. Am J Physiol (1983) 0.91
Pharmacokinetic considerations on monoclonal antibodies. Prog Clin Biol Res (1989) 0.91
Peritoneal absorption of macromolecules studied by quantitative autoradiography. Am J Physiol (1985) 0.90
Distributed model of peritoneal fluid absorption. Am J Physiol Heart Circ Physiol (2006) 0.87
A distributed model of peritoneal-plasma transport: tissue concentration gradients. Am J Physiol (1985) 0.86
In vivo effects of hydrostatic pressure on interstitium of abdominal wall muscle. Am J Physiol (1999) 0.83
In vivo hydraulic conductivity of muscle: effects of hydrostatic pressure. Am J Physiol (1997) 0.83
Effect of intraperitoneal pressures on tissue water of the abdominal muscle. Am J Physiol Renal Physiol (2000) 0.83
A distributed model of peritoneal-plasma transport: analysis of experimental data in the rat. Am J Physiol (1985) 0.81
Hydrostatic and osmotic pressures modulate partitioning of tissue water in abdominal muscle during dialysis. Perit Dial Int (1999) 0.80
Exchange of macromolecules between peritoneal cavity and plasma. Am J Physiol (1985) 0.80
Distribution of luminal carbonic anhydrase activity along rat inner medullary collecting duct. Am J Physiol (1991) 0.78
Estimation of Lymphatic Absorption and Intraperitoneal Volume During Hypertonic Peritoneal Dialysis. ASAIO Trans (1989) 0.78
A method to test blood flow limitation of peritoneal-blood solute transport. J Am Soc Nephrol (1997) 0.77
Tissue sources and blood flow limitations of osmotic water transport across the peritoneum. J Am Soc Nephrol (1999) 0.77
Model of ammonium and bicarbonate transport along LDL: implications for alkalinization of luminal fluid. Am J Physiol (1993) 0.76
Blood flow limitations of solute transport across the visceral peritoneum. J Am Soc Nephrol (1997) 0.75
Massive diflunisal overdosage with recovery. J Am Geriatr Soc (1989) 0.75
A tough diagnosis in a neutropenic patient: it's cat-scratch disease. JAMA (1989) 0.75
Prolongation of prothrombin time and severe gastrointestinal bleeding associated with combined use of warfarin and ketoprofen. JAMA (1988) 0.75
Laboratory study of sulfuric acid spill characteristics pertaining to maritime accidents. Environ Sci Technol (1982) 0.75
Concentration-dependent disappearance of fluorouracil from peritoneal fluid in the rat: experimental observations and distributed modeling. J Pharm Sci (1982) 0.75
NH4+ and NH3 permeabilities of Henle's loop segments. Contrib Nephrol (1994) 0.75